CGRP in cluster headache

Following the approval of galcanezumab for the treatment of episodic cluster headache and publication of the first positive clinical trial data, Peter Goadsby describes the research that led to this important advance and looks forward to better understanding of how treatment can be optimised for patients most likely to benefit.